ID   CTNB1_RAT               Reviewed;         781 AA.
AC   Q9WU82;
DT   01-DEC-2000, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1999, sequence version 1.
DT   02-OCT-2024, entry version 214.
DE   RecName: Full=Catenin beta-1 {ECO:0000312|RGD:70487};
DE   AltName: Full=Beta-catenin {ECO:0000303|PubMed:11867232};
GN   Name=Ctnnb1 {ECO:0000312|RGD:70487};
GN   Synonyms=Catnb {ECO:0000312|RGD:70487};
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   STRAIN=Sprague-Dawley; TISSUE=Testis;
RX   PubMed=10497305;
RX   DOI=10.1002/(sici)1097-4652(199911)181:2<258::aid-jcp8>3.0.co;2-q;
RA   Chung S.S.W., Lee W.M., Cheng C.Y.;
RT   "Study on the formation of specialized inter-Sertoli cell junctions in
RT   vitro.";
RL   J. Cell. Physiol. 181:258-272(1999).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC   STRAIN=Fischer 344;
RX   PubMed=11867232; DOI=10.1016/s0378-1119(01)00839-3;
RA   Li Q., Dixon B.M., Al-Fageeh M., Blum C.A., Dashwood R.H.;
RT   "Sequencing of the rat beta-catenin gene (Ctnnb1) and mutational analysis
RT   of liver tumors induced by 2-amino-3-methylimidazo[4,5-f]quinoline.";
RL   Gene 283:255-262(2002).
RN   [3]
RP   SUBCELLULAR LOCATION, AND IDENTIFICATION IN A COMPLEX WITH MACF1; APC;
RP   AXIN1 AND GSK3B.
RX   PubMed=16815997; DOI=10.1101/gad.1411206;
RA   Chen H.J., Lin C.M., Lin C.S., Perez-Olle R., Leung C.L., Liem R.K.;
RT   "The role of microtubule actin cross-linking factor 1 (MACF1) in the Wnt
RT   signaling pathway.";
RL   Genes Dev. 20:1933-1945(2006).
RN   [4]
RP   INTERACTION WITH FAT1.
RX   PubMed=16682528; DOI=10.1083/jcb.200508121;
RA   Hou R., Liu L., Anees S., Hiroyasu S., Sibinga N.E.;
RT   "The Fat1 cadherin integrates vascular smooth muscle cell growth and
RT   migration signals.";
RL   J. Cell Biol. 173:417-429(2006).
RN   [5]
RP   INTERACTION WITH CHD8.
RX   PubMed=10921920; DOI=10.1074/jbc.m004089200;
RA   Sakamoto I., Kishida S., Fukui A., Kishida M., Yamamoto H., Hino S.,
RA   Michiue T., Takada S., Asashima M., Kikuchi A.;
RT   "A novel beta-catenin-binding protein inhibits beta-catenin-dependent Tcf
RT   activation and axis formation.";
RL   J. Biol. Chem. 275:32871-32878(2000).
RN   [6]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-675, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=16641100; DOI=10.1073/pnas.0600895103;
RA   Hoffert J.D., Pisitkun T., Wang G., Shen R.-F., Knepper M.A.;
RT   "Quantitative phosphoproteomics of vasopressin-sensitive renal cells:
RT   regulation of aquaporin-2 phosphorylation at two sites.";
RL   Proc. Natl. Acad. Sci. U.S.A. 103:7159-7164(2006).
RN   [7]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-191; SER-552 AND SER-675, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22673903; DOI=10.1038/ncomms1871;
RA   Lundby A., Secher A., Lage K., Nordsborg N.B., Dmytriyev A., Lundby C.,
RA   Olsen J.V.;
RT   "Quantitative maps of protein phosphorylation sites across 14 different rat
RT   organs and tissues.";
RL   Nat. Commun. 3:876-876(2012).
CC   -!- FUNCTION: Key downstream component of the canonical Wnt signaling
CC       pathway (By similarity). In the absence of Wnt, forms a complex with
CC       AXIN1, AXIN2, APC, CSNK1A1 and GSK3B that promotes phosphorylation on
CC       N-terminal Ser and Thr residues and ubiquitination of CTNNB1 via BTRC
CC       and its subsequent degradation by the proteasome. In the presence of
CC       Wnt ligand, CTNNB1 is not ubiquitinated and accumulates in the nucleus,
CC       where it acts as a coactivator for transcription factors of the TCF/LEF
CC       family, leading to activate Wnt responsive genes (By similarity).
CC       Involved in the regulation of cell adhesion, as component of an E-
CC       cadherin:catenin adhesion complex (By similarity). Acts as a negative
CC       regulator of centrosome cohesion. Involved in the
CC       CDK2/PTPN6/CTNNB1/CEACAM1 pathway of insulin internalization. Blocks
CC       anoikis of malignant kidney and intestinal epithelial cells and
CC       promotes their anchorage-independent growth by down-regulating DAPK2.
CC       Disrupts PML function and PML-NB formation by inhibiting RANBP2-
CC       mediated sumoylation of PML (By similarity). Promotes neurogenesis by
CC       maintaining sympathetic neuroblasts within the cell cycle. Involved in
CC       chondrocyte differentiation via interaction with SOX9: SOX9-binding
CC       competes with the binding sites of TCF/LEF within CTNNB1, thereby
CC       inhibiting the Wnt signaling (By similarity). Acts as a positive
CC       regulator of odontoblast differentiation during mesenchymal tooth germ
CC       formation, via promoting the transcription of differentiation factors
CC       such as LEF1, BMP2 and BMP4 (By similarity). Activity is repressed in a
CC       MSX1-mediated manner at the bell stage of mesenchymal tooth germ
CC       formation which prevents premature differentiation of odontoblasts (By
CC       similarity). {ECO:0000250|UniProtKB:P35222,
CC       ECO:0000250|UniProtKB:Q02248}.
CC   -!- SUBUNIT: Two separate complex-associated pools are found in the
CC       cytoplasm. The majority is present as component of an E-cadherin/
CC       catenin adhesion complex composed of at least E-cadherin/CDH1 and beta-
CC       catenin/CTNNB1, and possibly alpha-catenin/CTNNA1; the complex is
CC       located to adherens junctions. The stable association of CTNNA1 is
CC       controversial as CTNNA1 was shown not to bind to F-actin when assembled
CC       in the complex. Alternatively, the CTNNA1-containing complex may be
CC       linked to F-actin by other proteins such as LIMA1. Another cytoplasmic
CC       pool is part of a large complex containing AXIN1, AXIN2, APC, CSNK1A1
CC       and GSK3B that promotes phosphorylation on N-terminal Ser and Thr
CC       residues and ubiquitination of CTNNB1. Interacts directly with AXIN1;
CC       the interaction is regulated by CK2 via BTRC and its subsequent
CC       degradation by the proteasome. Interacts directly with AXIN1; the
CC       interaction is regulated by CDK2 phosphorylation. Wnt-dependent
CC       activation of DVL antagonizes the action of GSK3B. When GSK3B activity
CC       is inhibited the complex dissociates, CTNNB1 is dephosphorylated and is
CC       no longer targeted for destruction. The stabilized protein translocates
CC       to the nucleus, where it binds TCF/LEF-1 family members, BCL9, BCL9L
CC       and possibly also RUVBL1 and CHD8. Binds CTNNBIP and EP300. CTNNB1
CC       forms a ternary complex with LEF1 and EP300 that is disrupted by
CC       CTNNBIP1 binding. Interacts with TAX1BP3 (via the PDZ domain); this
CC       interaction inhibits the transcriptional activity of CTNNB1. Interacts
CC       with AJAP1, BAIAP1, CARM1, CTNNA3, CXADR and PCDH11Y. Binds NHERF1.
CC       Interacts with GLIS2. Interacts with XIRP1. Interacts with PTPRU (via
CC       the cytoplasmic juxtamembrane domain) and with SLC30A9. Interacts with
CC       EMD. Interacts with SCRIB. Interacts with TNIK and TCF7L2. Interacts
CC       with SESTD1 and TRPC4. Interacts directly with AXIN1; the interaction
CC       is regulated by CDK2 phosphorylation of AXIN1. Interacts with CAV1.
CC       Interacts with TRPV4. The TRPV4 and CTNNB1 complex can interact with
CC       CDH1. Interacts with VCL. Interacts with PTPRJ. Interacts with PKT7.
CC       Interacts with NANOS1. Interacts with CDK2, NDRG2, NEK2 and CDK5. Found
CC       in a complex composed of MACF1, APC, AXIN1, CTNNB1 and GSK3B. Interacts
CC       with PTK6. Interacts with SOX7; this interaction may lead to
CC       proteasomal degradation of active CTNNB1 and thus inhibition of
CC       Wnt/beta-catenin-stimulated transcription. Identified in a complex with
CC       HINT1 and MITF. Interacts with FHIT. The CTNNB1 and TCF4 complex
CC       interacts with PML. Interacts with FERMT2. Identified in a complex with
CC       TCF4 and FERMT2. Interacts with RAPGEF2. Interacts with FAT1 (via the
CC       cytoplasmic domain). Interacts with RORA. May interact with P-
CC       cadherin/CDH3. Interacts with RNF220 (By similarity). Interacts with
CC       CTNND2 (By similarity). Interacts (via the C-terminal region) with CBY1
CC       (By similarity). The complex composed, at least, of APC, CTNNB1 and
CC       GSK3B interacts with JPT1; the interaction requires the inactive form
CC       of GSK3B (phosphorylated at 'Ser-9'). Interacts with DLG5 (By
CC       similarity). Interacts with FAM53B; promoting translocation to the
CC       nucleus. Interacts with TMEM170B (By similarity). Interacts with AHI1
CC       (By similarity). Interacts with GID8 (By similarity). Component of an
CC       cadherin:catenin adhesion complex composed of at least of CDH26, beta-
CC       catenin/CTNNB1, alpha-catenin/CTNNA1 and p120 catenin/CTNND1 (By
CC       similarity). Forms a complex comprising APPL1, RUVBL2, APPL2, HDAC1 and
CC       HDAC2 (By similarity). Interacts with IRF2BPL; mediates the
CC       ubiquitination and degradation of CTNNB1 (By similarity). Interacts
CC       with AMFR (By similarity). Interacts with LMBR1L (By similarity).
CC       Interacts with SOX30; prevents interaction of CTNNB1 with TCF7L2/TCF4
CC       and leads to inhibition of Wnt signaling (By similarity). Interacts
CC       with SOX9; inhibiting CTNNB1 activity by competing with the binding
CC       sites of TCF/LEF within CTNNB1, thereby inhibiting the Wnt signaling
CC       (By similarity). Interacts with SPN/CD43 cytoplasmic tail (By
CC       similarity). Interacts (when phosphorylated at Tyr-333) with isoform M2
CC       of PKM (PKM2); promoting transcription activation (By similarity).
CC       Interacts with PKP2 (via HEAD domain) (By similarity). Interacts with
CC       CDH1 (By similarity). Interacts (when unphosphorylated) with FLYWCH1,
CC       perhaps preventing interaction of CTNNB1 with TCF4, and thereby
CC       regulating transcription activation; phosphorylation of CTNNB1 may
CC       inhibit the interaction (By similarity). Interacts (via the central
CC       armadillo domains) with probable transcriptional regulator ADNP (via N-
CC       terminal region); interaction is direct and stabilizes CTNNB1 by
CC       modulating its phosphorylation by glycogen synthase kinase-3 beta GSK3B
CC       (By similarity). {ECO:0000250|UniProtKB:P35222,
CC       ECO:0000250|UniProtKB:Q02248, ECO:0000269|PubMed:10921920,
CC       ECO:0000269|PubMed:16682528, ECO:0000269|PubMed:16815997}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:16815997}. Nucleus
CC       {ECO:0000269|PubMed:16815997}. Cytoplasm, cytoskeleton
CC       {ECO:0000269|PubMed:16815997}. Cell junction, adherens junction
CC       {ECO:0000250|UniProtKB:Q02248}. Cell junction
CC       {ECO:0000250|UniProtKB:B6V8E6}. Cell membrane
CC       {ECO:0000269|PubMed:16815997}. Cytoplasm, cytoskeleton, microtubule
CC       organizing center, centrosome {ECO:0000250|UniProtKB:P35222}.
CC       Cytoplasm, cytoskeleton, spindle pole {ECO:0000250|UniProtKB:P35222}.
CC       Synapse {ECO:0000250|UniProtKB:Q02248}. Cytoplasm, cytoskeleton, cilium
CC       basal body {ECO:0000250|UniProtKB:Q02248}. Note=Colocalized with
CC       RAPGEF2 and TJP1 at cell-cell contacts (By similarity). Cytoplasmic
CC       when it is un-stable (highly phosphorylated) or bound to CDH1.
CC       Translocates to the nucleus when it is stabilized (low level of
CC       phosphorylation). Interaction with GLIS2 and MUC1 promotes nuclear
CC       translocation. Interaction with EMD inhibits nuclear localization. The
CC       majority of beta-catenin is localized to the cell membrane. In
CC       interphase, colocalizes with CROCC between CEP250 puncta at the
CC       proximal end of centrioles, and this localization is dependent on CROCC
CC       and CEP250. In mitosis, when NEK2 activity increases, it localizes to
CC       centrosomes at spindle poles independent of CROCC. Colocalizes with
CC       CDK5 in the cell-cell contacts and plasma membrane of undifferentiated
CC       and differentiated neuroblastoma cells. Interaction with FAM53B
CC       promotes translocation to the nucleus (By similarity). Translocates to
CC       the nucleus in the presence of SNAIL1 (By similarity).
CC       {ECO:0000250|UniProtKB:B6V8E6, ECO:0000250|UniProtKB:P35222}.
CC   -!- TISSUE SPECIFICITY: Expressed in the testis.
CC   -!- DEVELOPMENTAL STAGE: Highly expressed at 30 dpc to 60 dpc in the
CC       testis. Reduced expression at 90 dpc.
CC   -!- PTM: Phosphorylation by GSK3B requires prior phosphorylation of Ser-45
CC       by another kinase. Phosphorylation proceeds then from Thr-41 to Ser-33.
CC       Phosphorylated by NEK2. EGF stimulates tyrosine phosphorylation.
CC       Phosphorylated on Ser-33 and Ser-37 by HIPK2. This phosphorylation
CC       triggers proteasomal degradation. Phosphorylation at Ser-552 by AMPK
CC       promotes stabilization of the protein, enhancing TCF/LEF-mediated
CC       transcription. Phosphorylation on Ser-191 and Ser-246 by CDK5.
CC       Phosphorylation by CDK2 regulates insulin internalization.
CC       Phosphorylation by PTK6 at Tyr-64, Tyr-142, Tyr-331 and/or Tyr-333 with
CC       the predominant site at Tyr-64 is not essential for inhibition of
CC       transcriptional activity. Phosphorylation by SRC at Tyr-333 promotes
CC       interaction with isoform M2 of PKM (PKM2); promoting transcription
CC       activation. {ECO:0000250|UniProtKB:P35222,
CC       ECO:0000250|UniProtKB:Q02248}.
CC   -!- PTM: Ubiquitinated by the SCF(BTRC) E3 ligase complex when
CC       phosphorylated by GSK3B, leading to its degradation. Ubiquitinated by a
CC       E3 ubiquitin ligase complex containing UBE2D1, SIAH1, CACYBP/SIP, SKP1,
CC       APC and TBL1X, leading to its subsequent proteasomal degradation (By
CC       similarity). Ubiquitinated and degraded following interaction with SOX9
CC       (By similarity). Ubiquitinated via 'Lys-11'- and 'Lys-29'-linked
CC       ubiquitin chains by UBR5, leading to its stabilization (By similarity).
CC       {ECO:0000250|UniProtKB:P35222, ECO:0000250|UniProtKB:Q02248}.
CC   -!- PTM: S-nitrosylation at Cys-619 within adherens junctions promotes
CC       VEGF-induced, NO-dependent endothelial cell permeability by disrupting
CC       interaction with E-cadherin, thus mediating disassembly adherens
CC       junctions. {ECO:0000250}.
CC   -!- PTM: O-glycosylation at Ser-23 decreases nuclear localization and
CC       transcriptional activity, and increases localization to the plasma
CC       membrane and interaction with E-cadherin CDH1.
CC       {ECO:0000250|UniProtKB:Q96S06}.
CC   -!- PTM: Deacetylated at Lys-49 by SIRT1. {ECO:0000250|UniProtKB:P35222}.
CC   -!- SIMILARITY: Belongs to the beta-catenin family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF121265; AAD28504.1; -; mRNA.
DR   EMBL; AF397179; AAK85253.1; -; Genomic_DNA.
DR   RefSeq; NP_445809.2; NM_053357.2.
DR   RefSeq; XP_008764913.1; XM_008766691.2.
DR   RefSeq; XP_017451425.1; XM_017595936.1.
DR   RefSeq; XP_017451426.1; XM_017595937.1.
DR   RefSeq; XP_017451428.1; XM_017595939.1.
DR   RefSeq; XP_017451429.1; XM_017595940.1.
DR   AlphaFoldDB; Q9WU82; -.
DR   SMR; Q9WU82; -.
DR   BioGRID; 249913; 154.
DR   CORUM; Q9WU82; -.
DR   DIP; DIP-37053N; -.
DR   IntAct; Q9WU82; 18.
DR   MINT; Q9WU82; -.
DR   STRING; 10116.ENSRNOP00000068620; -.
DR   GlyCosmos; Q9WU82; 1 site, No reported glycans.
DR   GlyGen; Q9WU82; 1 site.
DR   iPTMnet; Q9WU82; -.
DR   PhosphoSitePlus; Q9WU82; -.
DR   jPOST; Q9WU82; -.
DR   PaxDb; 10116-ENSRNOP00000026016; -.
DR   GeneID; 84353; -.
DR   KEGG; rno:84353; -.
DR   UCSC; RGD:70487; rat.
DR   AGR; RGD:70487; -.
DR   CTD; 1499; -.
DR   RGD; 70487; Ctnnb1.
DR   eggNOG; KOG4203; Eukaryota.
DR   InParanoid; Q9WU82; -.
DR   OrthoDB; 50711at2759; -.
DR   PhylomeDB; Q9WU82; -.
DR   TreeFam; TF317997; -.
DR   Reactome; R-RNO-195253; Degradation of beta-catenin by the destruction complex.
DR   Reactome; R-RNO-196299; Beta-catenin phosphorylation cascade.
DR   Reactome; R-RNO-201681; TCF dependent signaling in response to WNT.
DR   Reactome; R-RNO-201722; Formation of the beta-catenin:TCF transactivating complex.
DR   Reactome; R-RNO-3134973; LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production.
DR   Reactome; R-RNO-351906; Apoptotic cleavage of cell adhesion proteins.
DR   Reactome; R-RNO-3769402; Deactivation of the beta-catenin transactivating complex.
DR   Reactome; R-RNO-4086398; Ca2+ pathway.
DR   Reactome; R-RNO-4641262; Disassembly of the destruction complex and recruitment of AXIN to the membrane.
DR   Reactome; R-RNO-5218920; VEGFR2 mediated vascular permeability.
DR   Reactome; R-RNO-525793; Myogenesis.
DR   Reactome; R-RNO-8951430; RUNX3 regulates WNT signaling.
DR   Reactome; R-RNO-9762292; Regulation of CDH11 function.
DR   Reactome; R-RNO-9825892; Regulation of MITF-M-dependent genes involved in cell cycle and proliferation.
DR   PRO; PR:Q9WU82; -.
DR   Proteomes; UP000002494; Unplaced.
DR   GO; GO:0005912; C:adherens junction; IDA:RGD.
DR   GO; GO:0043296; C:apical junction complex; ISO:RGD.
DR   GO; GO:0045177; C:apical part of cell; ISO:RGD.
DR   GO; GO:0016324; C:apical plasma membrane; IDA:RGD.
DR   GO; GO:0016327; C:apicolateral plasma membrane; ISO:RGD.
DR   GO; GO:0016323; C:basolateral plasma membrane; ISO:RGD.
DR   GO; GO:0030877; C:beta-catenin destruction complex; ISS:UniProtKB.
DR   GO; GO:1990711; C:beta-catenin-ICAT complex; ISO:RGD.
DR   GO; GO:1990907; C:beta-catenin-TCF complex; ISO:RGD.
DR   GO; GO:0070369; C:beta-catenin-TCF7L2 complex; ISS:UniProtKB.
DR   GO; GO:0005923; C:bicellular tight junction; ISO:RGD.
DR   GO; GO:0016342; C:catenin complex; ISS:UniProtKB.
DR   GO; GO:0005938; C:cell cortex; ISS:UniProtKB.
DR   GO; GO:0030054; C:cell junction; ISS:UniProtKB.
DR   GO; GO:0071944; C:cell periphery; ISS:UniProtKB.
DR   GO; GO:0031253; C:cell projection membrane; ISO:RGD.
DR   GO; GO:0005911; C:cell-cell junction; ISS:UniProtKB.
DR   GO; GO:0005813; C:centrosome; ISS:UniProtKB.
DR   GO; GO:0005737; C:cytoplasm; IDA:ARUK-UCL.
DR   GO; GO:0005829; C:cytosol; ISO:RGD.
DR   GO; GO:0043198; C:dendritic shaft; IDA:RGD.
DR   GO; GO:0000791; C:euchromatin; ISO:RGD.
DR   GO; GO:0005916; C:fascia adherens; ISO:RGD.
DR   GO; GO:0016600; C:flotillin complex; ISO:RGD.
DR   GO; GO:0098978; C:glutamatergic synapse; ISO:RGD.
DR   GO; GO:0014704; C:intercalated disc; IDA:RGD.
DR   GO; GO:0030027; C:lamellipodium; ISO:RGD.
DR   GO; GO:0016328; C:lateral plasma membrane; IDA:RGD.
DR   GO; GO:0016020; C:membrane; IDA:UniProtKB.
DR   GO; GO:0031528; C:microvillus membrane; ISO:RGD.
DR   GO; GO:0031965; C:nuclear membrane; IDA:ARUK-UCL.
DR   GO; GO:0005634; C:nucleus; IDA:CACAO.
DR   GO; GO:0048471; C:perinuclear region of cytoplasm; IDA:RGD.
DR   GO; GO:0005886; C:plasma membrane; IDA:ARUK-UCL.
DR   GO; GO:0099092; C:postsynaptic density, intracellular component; ISO:RGD.
DR   GO; GO:0045211; C:postsynaptic membrane; ISO:RGD.
DR   GO; GO:0098831; C:presynaptic active zone cytoplasmic component; ISO:RGD.
DR   GO; GO:0042734; C:presynaptic membrane; ISO:RGD.
DR   GO; GO:0032991; C:protein-containing complex; IDA:RGD.
DR   GO; GO:0032993; C:protein-DNA complex; ISS:UniProtKB.
DR   GO; GO:0090575; C:RNA polymerase II transcription regulator complex; ISO:RGD.
DR   GO; GO:0098685; C:Schaffer collateral - CA1 synapse; ISO:RGD.
DR   GO; GO:0034750; C:Scrib-APC-beta-catenin complex; ISO:RGD.
DR   GO; GO:0000922; C:spindle pole; IEA:UniProtKB-SubCell.
DR   GO; GO:0045202; C:synapse; ISO:RGD.
DR   GO; GO:0070160; C:tight junction; IDA:RGD.
DR   GO; GO:0005667; C:transcription regulator complex; ISS:UniProtKB.
DR   GO; GO:1990909; C:Wnt signalosome; ISO:RGD.
DR   GO; GO:0030018; C:Z disc; ISO:RGD.
DR   GO; GO:0045294; F:alpha-catenin binding; IPI:RGD.
DR   GO; GO:0045296; F:cadherin binding; IDA:RGD.
DR   GO; GO:0003682; F:chromatin binding; ISO:RGD.
DR   GO; GO:0070097; F:delta-catenin binding; IPI:RGD.
DR   GO; GO:0097718; F:disordered domain specific binding; ISO:RGD.
DR   GO; GO:0140297; F:DNA-binding transcription factor binding; ISO:RGD.
DR   GO; GO:0019899; F:enzyme binding; ISO:RGD.
DR   GO; GO:0070411; F:I-SMAD binding; ISO:RGD.
DR   GO; GO:0035255; F:ionotropic glutamate receptor binding; IPI:RGD.
DR   GO; GO:0019900; F:kinase binding; ISO:RGD.
DR   GO; GO:0140677; F:molecular function activator activity; ISO:RGD.
DR   GO; GO:0050998; F:nitric-oxide synthase binding; IPI:RGD.
DR   GO; GO:0030331; F:nuclear estrogen receptor binding; ISO:RGD.
DR   GO; GO:0016922; F:nuclear receptor binding; ISO:RGD.
DR   GO; GO:0003676; F:nucleic acid binding; ISO:RGD.
DR   GO; GO:0019901; F:protein kinase binding; ISO:RGD.
DR   GO; GO:0019903; F:protein phosphatase binding; ISO:RGD.
DR   GO; GO:0044877; F:protein-containing complex binding; IPI:RGD.
DR   GO; GO:0061629; F:RNA polymerase II-specific DNA-binding transcription factor binding; ISS:UniProtKB.
DR   GO; GO:0005102; F:signaling receptor binding; ISO:RGD.
DR   GO; GO:0046332; F:SMAD binding; ISO:RGD.
DR   GO; GO:0003713; F:transcription coactivator activity; ISS:UniProtKB.
DR   GO; GO:0001221; F:transcription coregulator binding; ISO:RGD.
DR   GO; GO:0001222; F:transcription corepressor binding; ISO:RGD.
DR   GO; GO:0044325; F:transmembrane transporter binding; ISO:RGD.
DR   GO; GO:0031625; F:ubiquitin protein ligase binding; ISO:RGD.
DR   GO; GO:0090425; P:acinar cell differentiation; ISO:RGD.
DR   GO; GO:0034333; P:adherens junction assembly; ISS:UniProtKB.
DR   GO; GO:0034332; P:adherens junction organization; ISO:RGD.
DR   GO; GO:0048513; P:animal organ development; ISO:RGD.
DR   GO; GO:0009948; P:anterior/posterior axis specification; ISO:RGD.
DR   GO; GO:0097190; P:apoptotic signaling pathway; ISO:RGD.
DR   GO; GO:0036520; P:astrocyte-dopaminergic neuron signaling; ISO:RGD.
DR   GO; GO:0046849; P:bone remodeling; IEP:RGD.
DR   GO; GO:0045453; P:bone resorption; ISO:RGD.
DR   GO; GO:0001569; P:branching involved in blood vessel morphogenesis; ISO:RGD.
DR   GO; GO:0001658; P:branching involved in ureteric bud morphogenesis; ISO:RGD.
DR   GO; GO:0060070; P:canonical Wnt signaling pathway; ISS:UniProtKB.
DR   GO; GO:0044338; P:canonical Wnt signaling pathway involved in mesenchymal stem cell differentiation; ISO:RGD.
DR   GO; GO:0007155; P:cell adhesion; ISS:UniProtKB.
DR   GO; GO:0030154; P:cell differentiation; ISO:RGD.
DR   GO; GO:0001708; P:cell fate specification; ISO:RGD.
DR   GO; GO:0048469; P:cell maturation; ISO:RGD.
DR   GO; GO:0000902; P:cell morphogenesis; ISO:RGD.
DR   GO; GO:0008283; P:cell population proliferation; ISO:RGD.
DR   GO; GO:0098609; P:cell-cell adhesion; IDA:RGD.
DR   GO; GO:0007160; P:cell-matrix adhesion; ISO:RGD.
DR   GO; GO:0044344; P:cellular response to fibroblast growth factor stimulus; IEP:RGD.
DR   GO; GO:0071363; P:cellular response to growth factor stimulus; ISS:UniProtKB.
DR   GO; GO:0071681; P:cellular response to indole-3-methanol; ISS:UniProtKB.
DR   GO; GO:1990314; P:cellular response to insulin-like growth factor stimulus; IMP:RGD.
DR   GO; GO:0071285; P:cellular response to lithium ion; IEP:RGD.
DR   GO; GO:0071260; P:cellular response to mechanical stimulus; IDA:RGD.
DR   GO; GO:0034224; P:cellular response to zinc ion starvation; IEP:RGD.
DR   GO; GO:0022009; P:central nervous system vasculogenesis; ISO:RGD.
DR   GO; GO:0007268; P:chemical synaptic transmission; ISO:RGD.
DR   GO; GO:0002062; P:chondrocyte differentiation; ISO:RGD.
DR   GO; GO:0061550; P:cranial ganglion development; ISO:RGD.
DR   GO; GO:1904888; P:cranial skeletal system development; ISO:RGD.
DR   GO; GO:0006351; P:DNA-templated transcription; ISO:RGD.
DR   GO; GO:1990791; P:dorsal root ganglion development; ISO:RGD.
DR   GO; GO:0009950; P:dorsal/ventral axis specification; ISO:RGD.
DR   GO; GO:0009953; P:dorsal/ventral pattern formation; ISO:RGD.
DR   GO; GO:0007398; P:ectoderm development; ISO:RGD.
DR   GO; GO:0000578; P:embryonic axis specification; ISO:RGD.
DR   GO; GO:1990403; P:embryonic brain development; ISO:RGD.
DR   GO; GO:0042733; P:embryonic digit morphogenesis; ISO:RGD.
DR   GO; GO:0048617; P:embryonic foregut morphogenesis; ISO:RGD.
DR   GO; GO:0035115; P:embryonic forelimb morphogenesis; ISO:RGD.
DR   GO; GO:0035050; P:embryonic heart tube development; ISO:RGD.
DR   GO; GO:0035116; P:embryonic hindlimb morphogenesis; ISO:RGD.
DR   GO; GO:0048568; P:embryonic organ development; ISO:RGD.
DR   GO; GO:0036023; P:embryonic skeletal limb joint morphogenesis; ISO:RGD.
DR   GO; GO:0001706; P:endoderm formation; ISO:RGD.
DR   GO; GO:0001711; P:endodermal cell fate commitment; ISO:RGD.
DR   GO; GO:0061154; P:endothelial tube morphogenesis; ISS:UniProtKB.
DR   GO; GO:1905867; P:epididymis development; IEP:RGD.
DR   GO; GO:0060742; P:epithelial cell differentiation involved in prostate gland development; ISO:RGD.
DR   GO; GO:0060767; P:epithelial cell proliferation involved in prostate gland development; ISO:RGD.
DR   GO; GO:0060441; P:epithelial tube branching involved in lung morphogenesis; ISO:RGD.
DR   GO; GO:0060856; P:establishment of blood-brain barrier; ISO:RGD.
DR   GO; GO:1990963; P:establishment of blood-retinal barrier; ISO:RGD.
DR   GO; GO:0008543; P:fibroblast growth factor receptor signaling pathway; ISO:RGD.
DR   GO; GO:0030900; P:forebrain development; ISO:RGD.
DR   GO; GO:0061198; P:fungiform papilla formation; ISO:RGD.
DR   GO; GO:0001702; P:gastrulation with mouth forming second; ISO:RGD.
DR   GO; GO:0010467; P:gene expression; ISO:RGD.
DR   GO; GO:0035112; P:genitalia morphogenesis; ISO:RGD.
DR   GO; GO:0002067; P:glandular epithelial cell differentiation; ISO:RGD.
DR   GO; GO:0007403; P:glial cell fate determination; ISO:RGD.
DR   GO; GO:0022405; P:hair cycle process; ISO:RGD.
DR   GO; GO:0031069; P:hair follicle morphogenesis; ISO:RGD.
DR   GO; GO:0060789; P:hair follicle placode formation; ISO:RGD.
DR   GO; GO:0007507; P:heart development; ISO:RGD.
DR   GO; GO:0030097; P:hemopoiesis; ISO:RGD.
DR   GO; GO:0030902; P:hindbrain development; ISO:RGD.
DR   GO; GO:0021854; P:hypothalamus development; ISO:RGD.
DR   GO; GO:0001701; P:in utero embryonic development; ISO:RGD.
DR   GO; GO:0001822; P:kidney development; ISO:RGD.
DR   GO; GO:0021819; P:layer formation in cerebral cortex; ISO:RGD.
DR   GO; GO:0002089; P:lens morphogenesis in camera-type eye; ISO:RGD.
DR   GO; GO:0060173; P:limb development; ISO:RGD.
DR   GO; GO:0001889; P:liver development; IEP:RGD.
DR   GO; GO:0060479; P:lung cell differentiation; ISO:RGD.
DR   GO; GO:0030324; P:lung development; ISO:RGD.
DR   GO; GO:0060487; P:lung epithelial cell differentiation; ISO:RGD.
DR   GO; GO:0060492; P:lung induction; ISO:RGD.
DR   GO; GO:0060484; P:lung-associated mesenchyme development; ISO:RGD.
DR   GO; GO:0030539; P:male genitalia development; ISO:RGD.
DR   GO; GO:0000165; P:MAPK cascade; ISO:RGD.
DR   GO; GO:0010463; P:mesenchymal cell proliferation; ISO:RGD.
DR   GO; GO:0060916; P:mesenchymal cell proliferation involved in lung development; ISO:RGD.
DR   GO; GO:0072497; P:mesenchymal stem cell differentiation; ISO:RGD.
DR   GO; GO:0003338; P:metanephros morphogenesis; ISO:RGD.
DR   GO; GO:0030901; P:midbrain development; ISO:RGD.
DR   GO; GO:1904948; P:midbrain dopaminergic neuron differentiation; ISO:RGD.
DR   GO; GO:0007494; P:midgut development; IEP:RGD.
DR   GO; GO:0016331; P:morphogenesis of embryonic epithelium; ISO:RGD.
DR   GO; GO:0045445; P:myoblast differentiation; IEP:RGD.
DR   GO; GO:0051450; P:myoblast proliferation; ISO:RGD.
DR   GO; GO:0016525; P:negative regulation of angiogenesis; ISO:RGD.
DR   GO; GO:0043066; P:negative regulation of apoptotic process; ISO:RGD.
DR   GO; GO:2001234; P:negative regulation of apoptotic signaling pathway; ISO:RGD.
DR   GO; GO:0090090; P:negative regulation of canonical Wnt signaling pathway; ISO:RGD.
DR   GO; GO:0045596; P:negative regulation of cell differentiation; ISO:RGD.
DR   GO; GO:0008285; P:negative regulation of cell population proliferation; ISS:UniProtKB.
DR   GO; GO:0032331; P:negative regulation of chondrocyte differentiation; ISO:RGD.
DR   GO; GO:0045892; P:negative regulation of DNA-templated transcription; ISS:UniProtKB.
DR   GO; GO:0010629; P:negative regulation of gene expression; IMP:BHF-UCL.
DR   GO; GO:0003340; P:negative regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis; ISO:RGD.
DR   GO; GO:0045976; P:negative regulation of mitotic cell cycle, embryonic; ISS:UniProtKB.
DR   GO; GO:0050768; P:negative regulation of neurogenesis; ISO:RGD.
DR   GO; GO:0043524; P:negative regulation of neuron apoptotic process; ISO:RGD.
DR   GO; GO:0048715; P:negative regulation of oligodendrocyte differentiation; ISO:RGD.
DR   GO; GO:0045671; P:negative regulation of osteoclast differentiation; ISO:RGD.
DR   GO; GO:1903377; P:negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway; ISO:RGD.
DR   GO; GO:0033234; P:negative regulation of protein sumoylation; ISS:UniProtKB.
DR   GO; GO:0000122; P:negative regulation of transcription by RNA polymerase II; ISO:RGD.
DR   GO; GO:0072079; P:nephron tubule formation; ISO:RGD.
DR   GO; GO:0001840; P:neural plate development; ISO:RGD.
DR   GO; GO:0007405; P:neuroblast proliferation; ISO:RGD.
DR   GO; GO:0030182; P:neuron differentiation; ISO:RGD.
DR   GO; GO:0048664; P:neuron fate determination; ISO:RGD.
DR   GO; GO:0001764; P:neuron migration; ISO:RGD.
DR   GO; GO:1990138; P:neuron projection extension; ISS:UniProtKB.
DR   GO; GO:0042475; P:odontogenesis of dentin-containing tooth; IEP:RGD.
DR   GO; GO:0048709; P:oligodendrocyte differentiation; ISO:RGD.
DR   GO; GO:0048599; P:oocyte development; ISO:RGD.
DR   GO; GO:0001649; P:osteoblast differentiation; ISO:RGD.
DR   GO; GO:0030316; P:osteoclast differentiation; ISO:RGD.
DR   GO; GO:0003151; P:outflow tract morphogenesis; ISO:RGD.
DR   GO; GO:0060066; P:oviduct development; ISO:RGD.
DR   GO; GO:0031016; P:pancreas development; ISO:RGD.
DR   GO; GO:0043065; P:positive regulation of apoptotic process; ISS:UniProtKB.
DR   GO; GO:0061047; P:positive regulation of branching involved in lung morphogenesis; ISO:RGD.
DR   GO; GO:0008284; P:positive regulation of cell population proliferation; ISO:RGD.
DR   GO; GO:2000017; P:positive regulation of determination of dorsal identity; ISO:RGD.
DR   GO; GO:0045893; P:positive regulation of DNA-templated transcription; ISS:UniProtKB.
DR   GO; GO:0045603; P:positive regulation of endothelial cell differentiation; ISO:RGD.
DR   GO; GO:0030858; P:positive regulation of epithelial cell differentiation; ISO:RGD.
DR   GO; GO:0060769; P:positive regulation of epithelial cell proliferation involved in prostate gland development; ISO:RGD.
DR   GO; GO:0010718; P:positive regulation of epithelial to mesenchymal transition; ISO:RGD.
DR   GO; GO:0045743; P:positive regulation of fibroblast growth factor receptor signaling pathway; ISO:RGD.
DR   GO; GO:0010628; P:positive regulation of gene expression; ISO:RGD.
DR   GO; GO:0010909; P:positive regulation of heparan sulfate proteoglycan biosynthetic process; ISS:UniProtKB.
DR   GO; GO:0043410; P:positive regulation of MAPK cascade; ISO:RGD.
DR   GO; GO:0002053; P:positive regulation of mesenchymal cell proliferation; ISO:RGD.
DR   GO; GO:2000288; P:positive regulation of myoblast proliferation; ISO:RGD.
DR   GO; GO:2000179; P:positive regulation of neural precursor cell proliferation; ISO:RGD.
DR   GO; GO:0002052; P:positive regulation of neuroblast proliferation; ISS:UniProtKB.
DR   GO; GO:0043525; P:positive regulation of neuron apoptotic process; ISO:RGD.
DR   GO; GO:1901331; P:positive regulation of odontoblast differentiation; ISO:RGD.
DR   GO; GO:0045669; P:positive regulation of osteoblast differentiation; ISO:RGD.
DR   GO; GO:0048643; P:positive regulation of skeletal muscle tissue development; ISO:RGD.
DR   GO; GO:2000648; P:positive regulation of stem cell proliferation; ISO:RGD.
DR   GO; GO:0032212; P:positive regulation of telomere maintenance via telomerase; ISO:RGD.
DR   GO; GO:0045944; P:positive regulation of transcription by RNA polymerase II; ISS:UniProtKB.
DR   GO; GO:0032968; P:positive regulation of transcription elongation by RNA polymerase II; ISO:RGD.
DR   GO; GO:0043161; P:proteasome-mediated ubiquitin-dependent protein catabolic process; ISO:RGD.
DR   GO; GO:0008104; P:protein localization; ISO:RGD.
DR   GO; GO:0034394; P:protein localization to cell surface; ISS:UniProtKB.
DR   GO; GO:0000209; P:protein polyubiquitination; ISO:RGD.
DR   GO; GO:0009954; P:proximal/distal pattern formation; ISO:RGD.
DR   GO; GO:0042981; P:regulation of apoptotic process; ISO:RGD.
DR   GO; GO:0090279; P:regulation of calcium ion import; ISS:UniProtKB.
DR   GO; GO:0045595; P:regulation of cell differentiation; ISO:RGD.
DR   GO; GO:0042127; P:regulation of cell population proliferation; ISO:RGD.
DR   GO; GO:0030997; P:regulation of centriole-centriole cohesion; ISS:UniProtKB.
DR   GO; GO:0070602; P:regulation of centromeric sister chromatid cohesion; ISS:UniProtKB.
DR   GO; GO:0030856; P:regulation of epithelial cell differentiation; ISO:RGD.
DR   GO; GO:0010468; P:regulation of gene expression; ISO:RGD.
DR   GO; GO:0031641; P:regulation of myelination; ISO:RGD.
DR   GO; GO:0072182; P:regulation of nephron tubule epithelial cell differentiation; ISO:RGD.
DR   GO; GO:0045667; P:regulation of osteoblast differentiation; ISO:RGD.
DR   GO; GO:0045670; P:regulation of osteoclast differentiation; ISO:RGD.
DR   GO; GO:2000008; P:regulation of protein localization to cell surface; ISS:UniProtKB.
DR   GO; GO:0031396; P:regulation of protein ubiquitination; ISO:RGD.
DR   GO; GO:0003266; P:regulation of secondary heart field cardioblast proliferation; ISO:RGD.
DR   GO; GO:0048660; P:regulation of smooth muscle cell proliferation; ISS:UniProtKB.
DR   GO; GO:0051963; P:regulation of synapse assembly; ISO:RGD.
DR   GO; GO:0042129; P:regulation of T cell proliferation; ISO:RGD.
DR   GO; GO:0051884; P:regulation of timing of anagen; ISO:RGD.
DR   GO; GO:0006357; P:regulation of transcription by RNA polymerase II; ISO:RGD.
DR   GO; GO:0072053; P:renal inner medulla development; ISO:RGD.
DR   GO; GO:0072054; P:renal outer medulla development; ISO:RGD.
DR   GO; GO:0072033; P:renal vesicle formation; ISO:RGD.
DR   GO; GO:0014823; P:response to activity; IEP:RGD.
DR   GO; GO:0046686; P:response to cadmium ion; IEP:RGD.
DR   GO; GO:0034097; P:response to cytokine; IDA:RGD.
DR   GO; GO:0032355; P:response to estradiol; IEP:RGD.
DR   GO; GO:0043627; P:response to estrogen; IDA:RGD.
DR   GO; GO:0009725; P:response to hormone; IEP:RGD.
DR   GO; GO:0014070; P:response to organic cyclic compound; IEP:RGD.
DR   GO; GO:0009410; P:response to xenobiotic stimulus; ISO:RGD.
DR   GO; GO:0014010; P:Schwann cell proliferation; IMP:RGD.
DR   GO; GO:0001501; P:skeletal system development; ISO:RGD.
DR   GO; GO:0043588; P:skin development; ISO:RGD.
DR   GO; GO:0051145; P:smooth muscle cell differentiation; ISO:RGD.
DR   GO; GO:0072089; P:stem cell proliferation; ISO:RGD.
DR   GO; GO:0061549; P:sympathetic ganglion development; ISS:UniProtKB.
DR   GO; GO:0050808; P:synapse organization; ISO:RGD.
DR   GO; GO:0097091; P:synaptic vesicle clustering; ISO:RGD.
DR   GO; GO:0048489; P:synaptic vesicle transport; ISO:RGD.
DR   GO; GO:0030217; P:T cell differentiation; ISO:RGD.
DR   GO; GO:0033077; P:T cell differentiation in thymus; ISO:RGD.
DR   GO; GO:0048538; P:thymus development; ISO:RGD.
DR   GO; GO:0001894; P:tissue homeostasis; ISO:RGD.
DR   GO; GO:0060440; P:trachea formation; ISO:RGD.
DR   GO; GO:0060439; P:trachea morphogenesis; ISO:RGD.
DR   GO; GO:0006366; P:transcription by RNA polymerase II; ISO:RGD.
DR   GO; GO:0001944; P:vasculature development; ISO:RGD.
DR   GO; GO:0001570; P:vasculogenesis; ISO:RGD.
DR   CDD; cd21724; CTNNAbd_CTNNB1; 1.
DR   Gene3D; 1.25.10.10; Leucine-rich Repeat Variant; 1.
DR   InterPro; IPR011989; ARM-like.
DR   InterPro; IPR016024; ARM-type_fold.
DR   InterPro; IPR000225; Armadillo.
DR   InterPro; IPR013284; Beta-catenin.
DR   PANTHER; PTHR45976; ARMADILLO SEGMENT POLARITY PROTEIN; 1.
DR   PANTHER; PTHR45976:SF4; CATENIN BETA-1; 1.
DR   Pfam; PF00514; Arm; 4.
DR   PRINTS; PR01869; BCATNINFAMLY.
DR   SMART; SM00185; ARM; 12.
DR   SUPFAM; SSF48371; ARM repeat; 1.
DR   PROSITE; PS50176; ARM_REPEAT; 9.
PE   1: Evidence at protein level;
KW   Acetylation; Activator; Cell adhesion; Cell junction; Cell membrane;
KW   Cell projection; Cytoplasm; Cytoskeleton; Glycoprotein; Membrane;
KW   Neurogenesis; Nucleus; Phosphoprotein; Reference proteome; Repeat;
KW   S-nitrosylation; Synapse; Transcription; Transcription regulation;
KW   Ubl conjugation.
FT   INIT_MET        1
FT                   /note="Removed"
FT                   /evidence="ECO:0000250|UniProtKB:P35222"
FT   CHAIN           2..781
FT                   /note="Catenin beta-1"
FT                   /id="PRO_0000064273"
FT   REPEAT          151..191
FT                   /note="ARM 1"
FT   REPEAT          193..234
FT                   /note="ARM 2"
FT   REPEAT          235..276
FT                   /note="ARM 3"
FT   REPEAT          277..318
FT                   /note="ARM 4"
FT   REPEAT          319..360
FT                   /note="ARM 5"
FT   REPEAT          361..389
FT                   /note="ARM 6"
FT   REPEAT          400..441
FT                   /note="ARM 7"
FT   REPEAT          442..484
FT                   /note="ARM 8"
FT   REPEAT          489..530
FT                   /note="ARM 9"
FT   REPEAT          531..571
FT                   /note="ARM 10"
FT   REPEAT          594..636
FT                   /note="ARM 11"
FT   REPEAT          637..666
FT                   /note="ARM 12"
FT   REGION          2..23
FT                   /note="Interaction with VCL"
FT                   /evidence="ECO:0000250"
FT   REGION          34..57
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          156..178
FT                   /note="Interaction with BCL9"
FT                   /evidence="ECO:0000250"
FT   REGION          720..781
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          772..781
FT                   /note="Interaction with SCRIB"
FT                   /evidence="ECO:0000250"
FT   COMPBIAS        34..48
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOD_RES         2
FT                   /note="N-acetylalanine"
FT                   /evidence="ECO:0000250|UniProtKB:P35222"
FT   MOD_RES         23
FT                   /note="Phosphoserine; by GSK3-beta; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P35222"
FT   MOD_RES         29
FT                   /note="Phosphoserine; by GSK3-beta"
FT                   /evidence="ECO:0000250|UniProtKB:P35222"
FT   MOD_RES         33
FT                   /note="Phosphoserine; by GSK3-beta and HIPK2"
FT                   /evidence="ECO:0000250|UniProtKB:P35222"
FT   MOD_RES         37
FT                   /note="Phosphoserine; by GSK3-beta and HIPK2"
FT                   /evidence="ECO:0000250|UniProtKB:P35222"
FT   MOD_RES         41
FT                   /note="Phosphothreonine; by GSK3-beta"
FT                   /evidence="ECO:0000250|UniProtKB:P35222"
FT   MOD_RES         45
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P35222"
FT   MOD_RES         49
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:P35222"
FT   MOD_RES         64
FT                   /note="Phosphotyrosine; by PTK6"
FT                   /evidence="ECO:0000250|UniProtKB:P35222"
FT   MOD_RES         142
FT                   /note="Phosphotyrosine; by FYN and PTK6"
FT                   /evidence="ECO:0000250|UniProtKB:P35222"
FT   MOD_RES         191
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         246
FT                   /note="Phosphoserine; by CDK5"
FT                   /evidence="ECO:0000250|UniProtKB:P35222"
FT   MOD_RES         331
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0000250|UniProtKB:P35222"
FT   MOD_RES         333
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0000250|UniProtKB:P35222"
FT   MOD_RES         552
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         556
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:P35222"
FT   MOD_RES         619
FT                   /note="S-nitrosocysteine"
FT                   /evidence="ECO:0000250|UniProtKB:Q02248"
FT   MOD_RES         675
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:16641100,
FT                   ECO:0007744|PubMed:22673903"
FT   CARBOHYD        23
FT                   /note="O-linked (GlcNAc) serine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:Q96S06"
FT   CONFLICT        368
FT                   /note="P -> L (in Ref. 2; AAK85253)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   781 AA;  85455 MW;  9C29186B6DD54B87 CRC64;
     MATQADLMEL DMAMEPDRKA AVSHWQQQSY LDSGIHSGAT TTAPSLSGKG NPEEEDVDTS
     QVLYEWEQGF SQSFTQEQVA DIDGQYAMTR AQRVRAAMFP ETLDEGMQIP STQFDAAHPT
     NVQRLAEPSQ MLKHAVVNLI NYQDDAELAT RAIPELTKLL NDEDQVVVNK AAVMVHQLSK
     KEASRHAIMR SPQMVSAIVR TMQNTNDVET ARCTAGTLHN LSHHREGLLA IFKSGGIPAL
     VKMLGSPVDS VLFYAITTLH NLLLHQEGAK MAVRLAGGLQ KMVALLNKTN VKFLAITTDC
     LQILAYGNQE SKLIILASGG PQALVNIMRT YTYEKLLWTT SRVLKVLSVC SSNKPAIVEA
     GGMQALGPHL TDPSQRLVQN CLWTLRNLSD AATKQEGMEG LLGTLVQLLG SDDINVVTCA
     AGILSNLTCN NYKNKMMVCQ VGGIEALVRT VLRAGDREDI TEPAICALRH LTSRHQEAEM
     AQNAVRLHYG LPVVVKLLHP PSHWPLIKAT VGLIRNLALC PANHAPLREQ GAIPRLVQLL
     VRAHQDTQRR TSMGGTQQQF VEGVRMEEIV EGCTGALHIL ARDVHNRIVI RGLNTIPLFV
     QLLYSPIENI QRVAAGVLCE LAQDKEAAEA IEAEGATAPL TELLHSRNEG VATYAAAVLF
     RMSEDKPQDY KKRLSVELTS SLFRTEPMAW NETADLGLDI GAQGEALGYR QDDPSYRSFH
     SGGYGQDALG MDPMMEHEMG GHHPGADYPV DGLPDLGHAQ DLMDGLPPGD SNQLAWFDTD
     L
//
